Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies

University Hospital Basel

Status: Completed

Conditions: Drug Therapy Management

Treatments: Behavioral: Extended polymedication check

Study type: Observational

Funder types: Other

Identifiers

NCT02703727

evalPMC-OAC

Details and patient eligibility

About

Oral anticoagulation therapy (OAC) entails a high potential for adverse events and strict adherence is needed.Thus, medication review and identification of safety issues and knowledge gaps about OAC is critically important. The polymedication check (PMC) is a reimbursed intermediate medication review focusing on adherence and medication management for Swiss primary care. Investigators aime to assess the impact of the PMC extended with a semi-structured interview focusing on OAC.

Enrollment: 90 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• intake of an oral anticoagulant
• more than 3 drugs over at least 3 months prior to recruitment
• german language (written and spoken)
• medicines use in self management

Exclusion criteria

• living in a nursing home
• provision of polymedication check in the past

Trial design

90 participants in 1 patient group

OAC

Description:

Patients on oral anticoagulation therapy (OAC) will receive a pharmacists led medication review with a focus on anticoagulation therapy (extended polymedication check)

Treatment:

Behavioral: Extended polymedication check